Cite
Mizutani S, Nishio J, Kondo K, et al. Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice. Pharmaceuticals (Basel). 2021;14(5)doi: 10.3390/ph14050474.
Mizutani, S., Nishio, J., Kondo, K., Motomura, K., Yamada, Z., Masuoka, S., Yamada, S., Muraoka, S., Ishii, N., Kuboi, Y., Sendo, S., Mikami, T., Imai, T., & Nanki, T. (2021). Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice. Pharmaceuticals (Basel, Switzerland), 14(5), . https://doi.org/10.3390/ph14050474
Mizutani, Satoshi, et al. "Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice." Pharmaceuticals (Basel, Switzerland) vol. 14,5 (2021). doi: https://doi.org/10.3390/ph14050474
Mizutani S, Nishio J, Kondo K, Motomura K, Yamada Z, Masuoka S, Yamada S, Muraoka S, Ishii N, Kuboi Y, Sendo S, Mikami T, Imai T, Nanki T. Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice. Pharmaceuticals (Basel). 2021 May 17;14(5). doi: 10.3390/ph14050474. PMID: 34067842; PMCID: PMC8156344.
Copy
Download .nbib